KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Receivables - Net (2018 - 2024)

BioNTech SE's Receivables - Net history spans 7 years, with the latest figure at $1.6 billion for Q4 2024.

  • For Q4 2024, Receivables - Net fell 32.56% year-over-year to $1.6 billion; the TTM value through Dec 2024 reached $1.6 billion, down 32.56%, while the annual FY2024 figure was $1.6 billion, 32.05% down from the prior year.
  • Receivables - Net for Q4 2024 was $1.6 billion at BioNTech SE, down from $2.3 billion in the prior quarter.
  • Across five years, Receivables - Net topped out at $14.2 billion in Q4 2021 and bottomed at $197.3 million in Q4 2020.
  • The 5-year median for Receivables - Net is $2.3 billion (2023), against an average of $5.1 billion.
  • The largest annual shift saw Receivables - Net skyrocketed 7078.2% in 2021 before it crashed 68.18% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $197.3 million in 2020, then surged by 7078.2% to $14.2 billion in 2021, then tumbled by 48.53% to $7.3 billion in 2022, then plummeted by 68.18% to $2.3 billion in 2023, then crashed by 32.56% to $1.6 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Receivables - Net are $1.6 billion (Q4 2024), $2.3 billion (Q4 2023), and $7.3 billion (Q4 2022).